All SPOP mutations detected thus far in prostate cancer occur in the structurally defined substrate-binding motif (Barbieri et al., 2012; Zhuang et al., 2009), suggesting that the pathophysiology of SPOP mutations in prostate cancer is relevant to its function in substrate binding and degradation. The gene discussed is SPOP; the disease is prostate carcinoma.